Mah, Chui Yan
Nguyen, An Dieu Trang
Niijima, Takuto
Helm, Madison
Dehairs, Jonas http://orcid.org/0000-0002-6789-2264
Ryan, Feargal J. http://orcid.org/0000-0002-1565-4598
Ryan, Natalie
Quek, Lake-Ee
Hoy, Andrew J. http://orcid.org/0000-0003-3922-1137
Don, Anthony S.
Mills, Ian G.
Swinnen, Johannes V. http://orcid.org/0000-0002-7720-5077
Lynn, David J. http://orcid.org/0000-0003-4664-1404
Nassar, Zeyad D.
Butler, Lisa M. http://orcid.org/0000-0003-2698-3220
Funding for this research was provided by:
Movember Foundation (MRTA3, MRTA3, MRTA3)
Cancer Council South Australia (PRF1117)
Hospital Research Foundation (C-PJ-10-Prost-2020, C-PJ-10-Prost-2020)
Prostate Cancer Foundation of Australia (Future Leaders Award)
University of Adelaide (International PhD Scholarship)
Robinson Fellowship and funding from the University of Sydney
Stichting Tegen Kanker (F/2020/1417)
KU Leuven (C14/21/095)
EMBL Australia
Cancer Australia (ID2011672)
Article History
Received: 12 December 2022
Revised: 5 December 2023
Accepted: 13 December 2023
First Online: 12 January 2024
Competing interests
: The authors declare no competing interests.
: Prostate cancer tissues were collected from men undergoing robotic radical prostatectomy at St. Andrew’s Hospital (Adelaide, Australia) with written informed consent through the Australia Prostate Cancer BioResource. Ethical approval for the use of human prostate tumours was obtained from the Ethics Committees of the University of Adelaide (Adelaide, Australia; approval H-2012-016) and St Andrew’s Hospital (Adelaide, Australia; approval 80). The orthotopic xenograft studies were approved by the South Australian Health and Medical Research Institute Animal Ethics Committee (approval number SAM442.19). All procedures were carried out in accordance with the guidelines of the National Health and Medical Research Council of Australia.